Liu Bing, Goodwin Julie E
Department of Pediatrics, Yale University School of Medicine, New Haven CT 06520, USA.
Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven CT 06520, USA.
J Cell Signal. 2020;1(3):42-49.
Glucocorticoids are steroid hormones produced by the adrenal cortex in a circadian manner and they participate in many physiological and pathological processes. Synthetic glucocorticoids have been universally applied to treat inflammatory diseases and immune disorders. Due to their angiostatic property, glucocorticoids are often added to regimens for cancer treatment. In the current review, we summarize how glucocorticoids influence angiogenesis in common solid tumors based on literature from the last ten years. Usage of glucocorticoids can be a double-edged sword in the treatment of some malignancies. There are still unanswered questions about the role of glucocorticoids in the treatment regimens of some common cancers. Therefore, we suggest prudent and restricted administration of glucocorticoids to treat solid tumors.
糖皮质激素是肾上腺皮质以昼夜节律方式产生的类固醇激素,它们参与许多生理和病理过程。合成糖皮质激素已被广泛应用于治疗炎症性疾病和免疫紊乱。由于其血管生成抑制特性,糖皮质激素常被添加到癌症治疗方案中。在本综述中,我们基于过去十年的文献总结了糖皮质激素如何影响常见实体瘤中的血管生成。在某些恶性肿瘤的治疗中,糖皮质激素的使用可能是一把双刃剑。关于糖皮质激素在一些常见癌症治疗方案中的作用仍有未解决的问题。因此,我们建议谨慎且限制使用糖皮质激素来治疗实体瘤。